Platform & Strategies
Publications
HomePlatform & StrategiesPublications
| NO | Pipeline | Journal | Date | Title | Link | |
|---|---|---|---|---|---|---|
| 2 | ABL001 | Int J Mol Sci | 2020 | ABL001, a bispecific antibody targeting VEGF and DLL4, with chemotherapy, synergistically inhibits tumor progression in xenograft models |
|
|
| 1 | ABL001 | mAbs | 2016 | Simultaneous blockade of VEGF and Dll4 by HD105, a bispecific antibody, inhibits tumor progression and angiogenesis |
|
|
-
ABL001, a bispecific antibody targeting VEGF and DLL4, with chemotherapy, synergistically inhibits tumor progression in xenograft models
2020
-
Simultaneous blockade of VEGF and Dll4 by HD105, a bispecific antibody, inhibits tumor progression and angiogenesis
2016